Epithelial-mesenchymal interactions in pulmonary fibrosis.
Lung epithelial cells have emerged as a frequent target of injury, a driver of normal repair, and a key element in the pathobiology of fibrotic lung diseases. An important aspect of epithelial cells is their capacity to respond to microenvironmental cues by undergoing epithelial-mesenchymal transition (EMT). EMT is not simply widespread conversion of epithelial cells to fibroblasts but a graded response whereby epithelial cells reversibly acquire mesenchymal features and enhanced capacity for mesenchymal cross-talk. Recent studies elucidate distinct integrin-sensing systems that coordinate activity of TGFβ1, a critical signaling element regulating EMT, with the presence of proinflammatory signals and cell injury. Repeated injury superimposes persistent inflammation and hypoxia onto these highly regulated repair pathways, potentially overwhelming orderly repair and creating sustained fibrogenesis. Understanding specific signaling mechanisms driving the mesenchymal response to TGFβ1 may reveal therapeutics to attenuate fibrogenesis yet preserve the important homeostatic functions of TGFβ1.
Department of Medicine, Cardiovascular Research Institute, University of California, San Francisco, 94143, USA. hal.chapman@ucsf.edu
Harold A
HA
Chapman
D000818:Animals; D002277:Carcinoma / Q000473:pathology; D058750:Epithelial-Mesenchymal Transition; D005260:Female; D006706:Homeostasis / Q000502:physiology; D006801:Humans; D016023:Integrins / Q000502:physiology; D008175:Lung Neoplasms / Q000473:pathology; D008297:Male; D051379:Mice; D011658:Pulmonary Fibrosis / Q000473:pathology*; D015398:Signal Transduction / Q000502:physiology; D013234:Stem Cells / Q000502:physiology; D053773:Transforming Growth Factor beta1 / Q000502:physiology
D016023:Integrins; D053773:Transforming Growth Factor beta1